Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Acupuncture for the Treatment of Cancer Related Fatigue
A Phase II Study of Acupuncture for the Treatment of Cancer Related Fatigue in Children and Adolescents With Central Nervous System Tumors
Status: Enrolling
Updated:  2/3/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Acupuncture for the Treatment of Cancer Related Fatigue
A Phase II Study of Acupuncture for the Treatment of Cancer Related Fatigue in Children and Adolescents With Central Nervous System Tumors
Status: Enrolling
Updated: 2/3/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
MicroRNAs in Patients With Neurofibromatosis Type 1
MicroRNAs as Disease Markers for Central Nervous System Tumors in Patients With Neurofibromatosis Type 1
Status: Enrolling
Updated:  2/3/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
MicroRNAs in Patients With Neurofibromatosis Type 1
MicroRNAs as Disease Markers for Central Nervous System Tumors in Patients With Neurofibromatosis Type 1
Status: Enrolling
Updated: 2/3/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Farmington, CT
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Farmington, CT
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Miami, FL
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Orlando, FL
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Atlanta, GA
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Ames, IA
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Ames, IA
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Sioux City, IA
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Sioux City, IA
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Burlington, MA
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Burlington, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Kansas City, MO
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Rochester, NY
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Durham, NC
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Canton, OH
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Philadelphia, PA
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Providence, RI
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Providence, RI
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Nashville, TN
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated:  2/4/2016
GSK Investigational Site
mi
from
Kogarah,
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy
Status: Enrolling
Updated: 2/4/2016
GSK Investigational Site
mi
from
Kogarah,
Click here to add this to my saved trials
Safety of Vitamin D Supplementation in Older Persons
Safety of Vitamin D Supplementation in the Elderly
Status: Enrolling
Updated:  2/5/2016
University of Miami
mi
from
Miami, FL
Safety of Vitamin D Supplementation in Older Persons
Safety of Vitamin D Supplementation in the Elderly
Status: Enrolling
Updated: 2/5/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
A Pilot Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Adult Brain Tumor Patients
Status: Enrolling
Updated:  2/5/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
A Pilot Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Adult Brain Tumor Patients
Status: Enrolling
Updated: 2/5/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy
A Phase I Blinded, Randomized Feasibility Trial of Dietary Flaxseed Administration in Non-Small Cell Lung Cancer Patients Receiving Definitive Thoracic Chemoradiotherapy
Status: Enrolling
Updated:  2/9/2016
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy
A Phase I Blinded, Randomized Feasibility Trial of Dietary Flaxseed Administration in Non-Small Cell Lung Cancer Patients Receiving Definitive Thoracic Chemoradiotherapy
Status: Enrolling
Updated: 2/9/2016
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
Status: Enrolling
Updated:  2/10/2016
Froedtert Hospital, Medical College of Wisconsin
mi
from
Milwaukee, WI
Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
Status: Enrolling
Updated: 2/10/2016
Froedtert Hospital, Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue?
Status: Enrolling
Updated:  2/12/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue?
Status: Enrolling
Updated: 2/12/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
University of AZ College of Medicine
mi
from
Tucson, AZ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
University of AZ College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Center for Clinical Research
mi
from
Castro Valley, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
ILD Consulting, Inc.
mi
from
Encinitas, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
ILD Consulting, Inc.
mi
from
Encinitas, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Vascular Surgery Associates
mi
from
Los Angeles, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Vascular Surgery Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
UCSD Wound Treatment and Research Center
mi
from
San Diego, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
UCSD Wound Treatment and Research Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
University of Miami
mi
from
Miami, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Doctors Research Network
mi
from
South Miami, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Doctors Research Network
mi
from
South Miami, FL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Robert J. Snyder
mi
from
Tamarac, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Robert J. Snyder
mi
from
Tamarac, FL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Passavant Area Hospital
mi
from
Jacksonville, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Passavant Area Hospital
mi
from
Jacksonville, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Rosalind Franklin University
mi
from
North Chicago, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Rosalind Franklin University
mi
from
North Chicago, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Southern Illinois University
mi
from
Springfield, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Southern Illinois University
mi
from
Springfield, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Johns Hopkins Wound Center
mi
from
Baltimore, MD
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Johns Hopkins Wound Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Boston Med Ctr
mi
from
Boston, MA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
New England Sinai Hospital
mi
from
Stoughton, MA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
New England Sinai Hospital
mi
from
Stoughton, MA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Vincent Giacalone
mi
from
Emerson, NJ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Vincent Giacalone
mi
from
Emerson, NJ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
St. Luke's Roosevelt Hospital Center
mi
from
New York, NJ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
St. Luke's Roosevelt Hospital Center
mi
from
New York, NJ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Overlook Hospital Wound Healing Program
mi
from
Summit, NJ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Overlook Hospital Wound Healing Program
mi
from
Summit, NJ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Harrisburg Foot and Ankle Center
mi
from
Harrisburg, PA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Harrisburg Foot and Ankle Center
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Center for Advanced Wound Care
mi
from
Reading, PA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Center for Advanced Wound Care
mi
from
Reading, PA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Arlington Research Center
mi
from
Arlington, TX
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Arlington Research Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Wound Care Consultants
mi
from
Dallas, TX
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Wound Care Consultants
mi
from
Dallas, TX
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Peripheral Vascular Associates
mi
from
San Antonio, TX
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Peripheral Vascular Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Dixie Regional Medical Center's Wound Clinic
mi
from
St. George, UT
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dixie Regional Medical Center's Wound Clinic
mi
from
St. George, UT
Click here to add this to my saved trials